Trilogy Capital’s Procter & Gamble PG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$835K Sell
5,692
-933
-14% -$136K 0.03% 218
2026
Q1
$957K Buy
6,625
+336
+5% +$50.9K 0.04% 194
2025
Q4
$901K Buy
6,289
+67
+1% +$9.88K 0.04% 197
2025
Q3
$956K Buy
6,222
+122
+2% +$19.1K 0.04% 188
2025
Q2
$972K Buy
6,100
+17
+0.3% +$2.77K 0.05% 180
2025
Q1
$1.04M Buy
6,083
+1,747
+40% +$293K 0.05% 171
2024
Q4
$727K Sell
4,336
-10
-0.2% -$1.7K 0.04% 193
2024
Q3
$753K Sell
4,346
-95
-2% -$16.1K 0.04% 191
2024
Q2
$732K Buy
4,441
+678
+18% +$111K 0.04% 188
2024
Q1
$611K Buy
3,763
+1,981
+111% +$311K 0.04% 177
2023
Q4
$261K Sell
1,782
-30
-2% -$4.44K 0.02% 222
2023
Q3
$264K Sell
1,812
-727
-29% -$111K 0.02% 216
2023
Q2
$388K Buy
2,539
+379
+18% +$57.1K 0.02% 193
2023
Q1
$321K Buy
2,160
+39
+2% +$5.58K 0.02% 200
2022
Q4
$321K Buy
+2,121
New +$297K 0.02% 191
2022
Q1
Sell
-23,891
Closed -$3.91M 194
2021
Q4
$3.91M Buy
23,891
+81
+0.3% +$12K 0.29% 53
2021
Q3
$3.33M Hold
23,810
0.25% 57
2021
Q2
$3.27M Buy
+23,810
New +$3.22M 0.24% 57
2020
Q1
Sell
-24,370
Closed -$2.97M 137
2019
Q4
$2.97M Buy
24,370
+1
+0% +$122 0.29% 55
2019
Q3
$3.02M Sell
24,369
-790
-3% -$93.3K 0.32% 55
2019
Q2
$2.86M Buy
25,159
+1,271
+5% +$135K 0.32% 53
2019
Q1
$2.49M Sell
23,888
-3,317
-12% -$323K 0.3% 57
2018
Q4
$2.5M Sell
27,205
-528
-2% -$47.2K 0.34% 48
2018
Q3
$2.31M Sell
27,733
-813
-3% -$66.5K 0.29% 38
2018
Q2
$2.23M Sell
28,546
-507
-2% -$38.2K 0.3% 35
2018
Q1
$2.3M Buy
29,053
+5,290
+22% +$441K 0.33% 34
2017
Q4
$2.18M Buy
+23,763
New +$2.14M 0.35% 33

Other funds holding PG

Trilogy Capital's PG Position: Q2 2026 in Review

Trilogy Capital reduced its Procter & Gamble (PG) stake by 14% in Q2 2026, selling an estimated $136K and leaving 5,692 shares worth $835K. The position accounts for 0.03% of the portfolio, ranked #218.

Trilogy Capital first reported a position in PG in Q4 2017 and has held it in 27 quarters since. The position peaked at $3.91M in Q4 2021. 4,006 funds tracked by Wall St. Rank hold PG as of Q2 2026.

  • Trilogy Capital held 5,692 shares of Procter & Gamble worth $835K as of Q2 2026.
  • Trilogy Capital sold 933 Procter & Gamble shares in Q2 2026, an estimated $136K.
  • Procter & Gamble made up 0.03% of Trilogy Capital's portfolio in Q2 2026, its #218 holding.
  • Trilogy Capital first reported a position in Procter & Gamble in Q4 2017 and has held it in 27 quarters since.
  • Trilogy Capital's Procter & Gamble position peaked at $3.91M in Q4 2021.
  • 4,006 funds tracked by Wall St. Rank held Procter & Gamble as of Q2 2026.

Based on Trilogy Capital's 13F filing for Q2 2026, filed 6 Jul 2026.